This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to H2-Pharma LLC, a for-profit limited liability company, to provide pharmaceuticals and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, is a multiple award vehicle that allows federal agencies to procure the...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
The Federal Supply Schedule (FSS) contract 36F79718D0461 was awarded to Prime Contractor Para Pro LLC, a small disadvantaged business and veteran-owned manufacturer of goods, to provide pharmaceuticals and related hematology products. The contract has a $250,000 ceiling value and a performance period ending on May 31, 2025. This multiple award FSS contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and was awarded by the Department of Veterans Affairs, Veterans...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA), provides for the procurement of pharmaceutical and hematology-related products. The prime contractor, Orexo US Inc., is a for-profit manufacturer based in Morristown, New Jersey. The contract has a ceiling value of $225,000.00 and a period of performance through January 31, 2026. The scope of the contract encompasses the delivery of drugs, pharmaceuticals, and hematology-related products under...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,980,000.00 and a period of performance that runs through January 1, 2026. The contracted products and services under this multiple award FSS-61-IB schedule include drugs, pharmaceuticals, and hematology-related products. The prime contractor, Llorens Pharmaceutical International...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs. The contract has an award date of September 29, 2024 and a ceiling value of $225,000.00, with a period of performance through September 28, 2029. The contract is for the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under FSS category 65 I B. The prime contractor is Leading Pharma...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Metuchen Pharmaceuticals LLC. The contract is for Pharmaceuticals and Drugs (FSS-61-IB) and has a ceiling value of $6,800,000 with a period of performance through February 14, 2025. The contract aims to procure a variety of pharmaceutical and hematology-related products for the VA's Veterans Integrated Service Network 12. As an FSS contract, it allows for the VA and other federal agencies to...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...